To investigate the role of high-frequency ultrasound in detection of occult focal liver lesions (FLLs).
Methods
In this retrospective study from April 2016 to March 2019, eighty-five patients with indistinctive FLLs were included. High-frequency and low-frequency B-mode ultrasound (BMUS) and contrast-enhanced ultrasound (CEUS) were performed for each lesion. The detection rates of two methods and the ultrasound performance of co-detected lesions were compared. Subgroup analysis was performed according to different liver backgrounds.
Results
For 85 FLLs with mean diameter of 11.80 ± 4.66 mm and mean depth of 20.91 ± 6.89 mm, high-frequency BMUS detected 77 (90.6%) lesions, significantly more than low-frequency BMUS (36, 42.4%, p < 0.001). Among the lesions co-detected by low-frequency and high-frequency ultrasound, the lesions at high-frequency mainly showed heterogeneous echogenicity (p < 0.001), regular morphology (p < 0.001), well-defined boundary (p < 0.001) and inhomogeneous enhancement (p < 0.001) in arterial phase. Even in the presence of cirrhosis or fatty liver, high-frequency ultrasound still performed excellently.
Conclusion
High-frequency ultrasound improves the detection of small and superficially located FLLs.
PompiliMArditoFBrunettiE, et al.Benign liver lesions 2022: guideline for clinical practice of Associazione Italiana Studio del Fegato (AISF), Società Italiana di Radiologia Medica e Interventistica (SIRM), Società Italiana di Chirurgia (SIC), Società Italiana di Ultrasonologia in Medicina e Biologia (SIUMB), Associazione Italiana di Chirurgia Epatobilio-Pancreatica (AICEP), Società Italiana Trapianti d'Organo (SITO), Società Italiana di Anatomia Patologica e Citologia Diagnostica (SIAPEC-IAP) - Part I - Cystic lesions. Dig Liver Dis2022; 54: 1469–1478.
2.
ChoiHHRodgersSKFetzerDT, et al.Ultrasound liver imaging reporting and data system (US LI-RADS): an overview with technical and practical applications. Acad Radiol2021; 28: 1464–1476.
3.
DietrichCFNolsøe CPBarrRG, et al.Guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS) in the liver-update 2020 WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultrasound Med Biol2020; 46: 2579–2604.
4.
JeongWKKangHJChoiSH, et al.Diagnosing hepatocellular carcinoma using sonazoid contrast-enhanced ultrasonography: 2023 guidelines from the Korean society of radiology and the Korean society of abdominal radiology. Korean J Radiol2023; 24: 482–497.
5.
ParkJLeeJMKimTH, et al.Imaging diagnosis of hepatocellular carcinoma: future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound. Clin Mol Hepatol2022; 28: 362–379.
6.
SchellhaasBBernatikTBohleW, et al.Contrast-Enhanced ultrasound algorithms (CEUS-LIRADS/ESCULAP) for the noninvasive diagnosis of hepatocellular carcinoma - A prospective multicenter DEGUM. Study. Ultraschall Med2021; 42: 178–186.
7.
StrobelDBernatikTBlankW, et al.Diagnostic accuracy of CEUS in the differential diagnosis of small (≤20 mm) and subcentimetric (≤10 mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial. Ultraschall Med2011; 32: 593–597.
8.
BernatikTSeitzKBlankW, et al.Unclear focal liver lesions in contrast-enhanced ultrasonography–lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors. Ultraschall Med2010; 31(6): 577–581.
9.
StrobelDSeitzKBlankW, et al.Contrast-enhanced ultrasound for the characterization of focal liver lesions–diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall Med2008; 29: 499–505.
10.
DongYTeufelAWangWP, et al.Current opinion about hepatocellular carcinoma <10 mm. Digestion2021; 102: 335–341.
11.
ClevertDABeyerGNießH, et al.Ultrasound—new techniques are extending the applications. Dtsch Arztebl Int2023; 120: 41–47.
12.
QinSChenYLiuXY, et al.Clinical application of contrast-enhanced ultrasound using high-frequency linear probe in the detection of small colorectal liver metastases. Ultrasound Med Biol2017; 43: 2765–2773.
13.
WangWPDongYCaoJ, et al.Detection and characterization of small superficially located focal liver lesions by contrast-enhanced ultrasound with high frequency transducers. Med Ultrason2017; 19: 349–356.
14.
JungEMRossCJRennertJ, et al.Characterization of microvascularization of liver tumor lesions with high resolution linear ultrasound and contrast enhanced ultrasound (CEUS) during surgery: first results. Clin Hemorheol Microcirc2010; 46: 89–99.
15.
AhnJHEomDWRyuDS, et al.Synchronous multicentric small hepatocellular carcinomas: defining the capsule on high-frequency intraoperative ultrasonography with pathologic correlation. Ultrasonography2016; 35: 335–344.
16.
JungEMDongYJungF. Current aspects of multimodal ultrasound liver diagnostics using contrast-enhanced ultrasonography (CEUS), fat evaluation, fibrosis assessment, and perfusion analysis - an update. Clin Hemorheol Microcirc2023; 83: 181–193.
17.
JungEMMoranVOEngelM, et al.Modified contrast-enhanced ultrasonography with the new high-resolution examination technique of high frame rate contrast-enhanced ultrasound (HiFR-CEUS) for characterization of liver lesions: first results. Clin Hemorheol Microcirc2023; 83: 31–46.
18.
JungEMKaiserUHerrW, et al.Novel high-resolution contrast agent ultrasound techniques HiFR CEUS and SR CEUS in combination with shear wave elastography, fat assessment and viscosity of liver parenchymal changes and tumors. Clin Hemorheol Microcirc2024; 86: 263–273.
19.
PfeiferLGoertzRSSturmJ, et al.Acoustic radiation force impulse (ARFI) and high-frequency ultrasound of the liver surface for the diagnosis of compensated liver cirrhosis. Ultraschall Med2014; 35: 44–50.
20.
BorroPDellepianeSGPellicanoR, et al.Quantification of ultrasound imaging in the staging of hepatic fibrosis. Panminerva Med2018; 60: 44–51.
21.
FerralHMaleRCardielM, et al.Cirrhosis: diagnosis by liver surface analysis with high-frequency ultrasound. Gastrointest Radiol1992; 17: 74–78.
22.
PfeiferLZopfSSieblerJ, et al.Prospective evaluation of acoustic radiation force impulse (ARFI) elastography and high-frequency B-mode ultrasound in compensated patients for the diagnosis of liver fibrosis/cirrhosis in comparison to Mini-laparoscopic biopsy. Ultraschall Med2015; 36: 581–589.
23.
HuangJYLiJWLuQ, et al.Diagnostic accuracy of CEUS LI-RADS for the characterization of liver nodules 20 mm or smaller in patients at risk for hepatocellular carcinoma. Radiology2020; 294: 329–339.
24.
WiesingerIJungFJungEM. Contrast-enhanced ultrasound (CEUS) and perfusion imaging using VueBox®. Clin Hemorheol Microcirc2021; 78: 29–40.
25.
DongYKochJBHLöweAL, et al.Vuebox® for quantitative analysis of contrast-enhanced ultrasound in liver tumors1. Clin Hemorheol Microcirc2022; 80: 473–486.
26.
ChenSQiuYJZuoD, et al.Imaging Features of Hepatocellular Carcinoma in the Non-Cirrhotic Liver with Sonazoid-Enhanced Contrast-Enhanced Ultrasound. Diagnostics (Basel)2022; 12: 2272.
27.
GinèsPKragAAbraldesJG, et al.Liver cirrhosis. Lancet2021; 398: 1359–1376.
